177 related articles for article (PubMed ID: 7054763)
21. Pharmacokinetics of delayed (DR) versus sustained release (SR) theophylline formulations following single (SD) and repetitive dosing (RD).
Leung P; Katsampes C; Bell T
Ann Allergy; 1978 Nov; 41(5):285-7. PubMed ID: 717850
[TBL] [Abstract][Full Text] [Related]
22. Theophylline serum levels unmodified by postprandial administration of a sustained-release preparation (Teonova).
Cannizzaro GF; Pesce L; Zanoli P; Milani GF; Zannoni F; Pivirotto F
Int J Clin Pharmacol Res; 1988; 8(1):37-41. PubMed ID: 3366501
[TBL] [Abstract][Full Text] [Related]
23. Experience with theophylline for the management of chronic asthma.
Weinberger M; Hendeles L
Eur J Respir Dis Suppl; 1980; 109():120-33. PubMed ID: 6777183
[TBL] [Abstract][Full Text] [Related]
24. [Are theophylline determinations useful to the clinician during treatment with a sustained-release form of theophylline?].
Autret E; Lebranchu Y; Blanchard P; Nsabiyumua F; Breteau M; Grenier B; Jonville AP
Therapie; 1990; 45(1):19-22. PubMed ID: 2343431
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous use of rapidly absorbed and sustained release theophylline preparations in children.
Hein EW; Domson JF; Sheen A; Buffone GJ; Sly RM
Ann Allergy; 1979 Oct; 43(4):217-9. PubMed ID: 555597
[TBL] [Abstract][Full Text] [Related]
26. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
[TBL] [Abstract][Full Text] [Related]
27. [The evaluation parameters of the long-term treatment efficacy of theophylline in the child with bronchial asthma].
Panta P; Nanulescu MV; Palibroda N; Culea M
Pneumoftiziologia; 1997; 46(4):257-62. PubMed ID: 9654966
[TBL] [Abstract][Full Text] [Related]
28. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
[TBL] [Abstract][Full Text] [Related]
29. Rectal administration of theophylline in aqueous solution.
Pedersen S; Sommer B
Acta Paediatr Scand; 1981 Mar; 70(2):243-6. PubMed ID: 7234406
[TBL] [Abstract][Full Text] [Related]
30. Optimal time for obtaining peak and trough theophylline levels in 12-hour and 24-hour products in children.
Tinkelman DG; Lutz CN; Miller E; Cole WQ
Ann Allergy; 1987 Mar; 58(3):190-2. PubMed ID: 3826771
[TBL] [Abstract][Full Text] [Related]
31. [Measurement of blood theophylline levels in the child: will this affect methods of prescription? (author's transl)].
de Blic J; Scheinmann P; Menillet G; Santais MC; Ruff F; Paupe J
Nouv Presse Med; 1979 Apr; 8(16):1311-4. PubMed ID: 482098
[TBL] [Abstract][Full Text] [Related]
32. [Sustained-release theophylline: study in a child population].
Díaz Fernández M; Gracía Hidalgo A; Mateo Cañas G; López Elorze F
An Esp Pediatr; 1986 Jan; 24(1):7-13. PubMed ID: 3963648
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
Liebke C; Niggemann B; Wahn U
Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
[TBL] [Abstract][Full Text] [Related]
34. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
[TBL] [Abstract][Full Text] [Related]
35. Sustained release theophylline for the forgetful asthmatic.
Weinstein AG
Ann Allergy; 1985 Oct; 55(4):563-7. PubMed ID: 4051262
[TBL] [Abstract][Full Text] [Related]
36. [Determination of the mean dose of oral theophylline in asthmatic children (author's transl)].
Cabanas R; Peña J; Fuster M; Cortizo E; Castro-Gago M; Couselo JM; Tojo R
An Esp Pediatr; 1982 Feb; 16(2):119-26. PubMed ID: 7081857
[TBL] [Abstract][Full Text] [Related]
37. Serum theophylline profile with once-daily theophylline (Uniphyl) following conversion from intravenous theophylline in adult asthmatic patients.
Fradette M; Babich M; Friesen EG; Archibald JS; Babul N
Clin Ther; 1994; 16(2):160-8. PubMed ID: 8062311
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of Nuelin-SR 250 mg in asthmatic children: a new sustained-release theophylline.
Mitchell EA; Liang AY
N Z Med J; 1980 Aug; 92(665):91-3. PubMed ID: 6933343
[TBL] [Abstract][Full Text] [Related]
39. [Theophylline in the treatment of childhood asthma].
Zach M
Monatsschr Kinderheilkd; 1982 Sep; 130(9):696-703. PubMed ID: 7144760
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
Fuchs WS; Weiss G; Von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
